Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2025-12-25 @ 1:40 AM
NCT ID:
NCT02028494
Brief Title:
Evaluation of Response to Two Schedules of Capecitabine in Patients With Metastatic Breast Cancer
Official Title:
Evaluation of Response to Two Schedules of Capecitabine in Patients With Metastatic Breast Cancer
Acronym:
CAP7/7
Study:
NCT02028494
Protocol Section:
NCT02028494